Kai Lin

3.8k citations

50 papers · 2.0k indexed · h-index 25

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Virology top 5%
- HIV Research and Treatment

Papers in

Hepatology 27
- Hepatitis C virus research 27
Virology 4
- HIV Research and Treatment 4

Co-authors: Chao Lin Ann D. Kwong Robert B. Perni Sue Ma Philippe Gallay Robert P. Ricciardi Yu-Ping Luong Cynthia A. Gates
Journals: Antimicrobial Agents and Chemotherapy (10 papers)Journal of Biological Chemistry (5 papers)Journal of Hepatology (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Antiviral Research (2 papers)
Partner nations: United States Switzerland China

In The Last Decade

Kai Lin

50 papers receiving 1.9k citations

Peers

Countries citing papers authored by Kai Lin

Since Specialization

Citations

This map shows the geographic impact of Kai Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Lin more than expected).

Fields of papers citing papers by Kai Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Lin. The network helps show where Kai Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kai Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kai Lin Line = papers co-authored together Kai Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nomenclature of HBV core protein-targeting antivirals Nature Reviews Gastroenterology & Hepatology ·Fabien Zoulim, Adam Zlotnick, Stephanie Buchholz, Eric Donaldson, John Fry, Anuj Gaggar, Jianming Hu, Michael Kann, Oliver Lenz, Kai Lin, Nagraj Mani, Michael Nassal, William E. Delaney, Su Wang, Gabriel Westman, Veronica Miller, Harry L.A. Janssen	2022	40
2	EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model PLoS Pathogens ·Qianqian Song, T.D. Priest, Yaowu Yang, Sarah L. Noton, Rachel Fearns, In Jong Kim, Jianming Yu, KlassnerFrank, 舒晓莲, Brian C. Shook, Yat Sun Or, Bryan Goodwin, Kai Lin	2021	28
3	Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design Current Pharmaceutical Design ·Luqing Shang, Kai Lin, Zheng Yin	2014	6
4	Design and synthesis of lactam–thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors Bioorganic & Medicinal Chemistry Letters ·David Barnes‐Seeman, Guillaume Jeu, M. Schafer, Rajiv Chopra, Keith Hoffmaster, Christopher T. Jones, Mitsunori Kato, Kai Lin, Sue Ma, Guoyu Pan, Lei Shu, Jianling Wang, Ekta Chauhan, Phillip Lechler, Rui Zheng, Leena G. Adhikesavan	2014	15
5	Curing a viral infection by targeting the host: The example of cyclophilin inhibitors Antiviral Research ·Kai Lin, Philippe Gallay	2013	85
6	HCV NS5A and IRF9 compete for CypA binding Journal of Hepatology ·Michael Bobardt, Sam Hopkins, M.D. Maluleke, Udayan Chatterji, Agung Ariyani, John Hiscott, Ann E. Sluder, Kai Lin, Philippe Gallay	2012	21
7	Anti-HCV drugs in the pipeline Current Opinion in Virology ·Priscilla L. Yang, Min Gao, Kai Lin, Qingsong Liu, Valerie A. Villareal	2011	56
8	Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretion Virology Journal ·Leah J. Anderson, Kai Lin, Teresa Compton, Brigitte Wiedmann	2011	24
9	Development of novel antiviral therapies for hepatitis C virus Virologica Sinica ·Kai Lin	2010	19
10	Multiple cyclophilins involved in different cellular pathways mediate HCV replication Virology ·L. Alex Gaither, Jason Borawski, Leah J. Anderson, Seydou Bakayoko, Piroska Dévay, Gérard Joberty, Christina Rau, Markus Schirle, Tewis Bouwmeester, Craig Mickanin, Hervé Guillaumie, Chad Vickers, Shining Ma, Gejing Deng, Jeremy L. Baryza, Roger A. Fujimoto, Kai Lin, Teresa Compton, Brigitte Wiedmann	2009	75
11	Inhibitors of hepatitis C virus NS3·4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics Bioorganic & Medicinal Chemistry Letters ·Robert B. Perni, Gurudatt Chandorkar, Kevin M. Cottrell, Cynthia A. Gates, Chao Lin, Kai Lin, Yu-Ping Luong, John P. Maxwell, Mark A. Murcko, J. PITLIK, Ekaterina Lagun, Marina KOFFI, 蔡征, Yunyi Wei	2007	16
12	Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: In vitro and in vivo studies Cardiovascular Research ·George Hsiao, Jungmin Lee, Kai Lin, Cai Shen, Tse–Ling Fong, Danny M. Chou, JARRED INFANTE HERRERA	2007	39
13	In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061 Journal of Biological Chemistry ·Chao Lin, Cynthia A. Gates, B. Govinda Rao, Debra Brennan, John R. Fulghum, Yu-Ping Luong, J. Daniel Frantz, Kai Lin, Sue Ma, Yunyi Wei, Robert B. Perni, Ann D. Kwong	2005	170
14	c-Jun Regulates the Stability and Activity of the p53 Homologue, p73 Journal of Biological Chemistry ·Line Delagrange, Monowarul Mobin Siddique, Lakshmanane Boominathan, Kai Lin, Kanaga Sabapathy	2004	65
15	Multiple Stress Signals Induce p73β Accumulation Neoplasia ·Kai Lin, 王联合, Line Delagrange, Iqbal Dulloo, Kanaga Sabapathy	2004	45
16	Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization Bioorganic & Medicinal Chemistry Letters ·Robert B. Perni, J. PITLIK, OU Ming-le, John J. Court, Lawrence F. Courtney, David D. Deininger, Luc J. Farmer, Cynthia A. Gates, Scott L. Harbeson, Rhonda B. Levin, Chao Lin, Kai Lin, Young‐Choon Moon, Yu-Ping Luong, I. V. Gel’Tser, B. Govinda Rao, John A. Thomson, Roger D. Tung, John H. Van Drie, Yunyi Wei	2004	41
17	In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061 Journal of Biological Chemistry ·Chao Lin, Kai Lin, Yu-Ping Luong, B. Govinda Rao, Yunyi Wei, Debra Brennan, John R. Fulghum, 末包伸吾, Sue Ma, John P. Maxwell, Kevin M. Cottrell, Robert B. Perni, Cynthia A. Gates, Ann D. Kwong	2004	228
18	Human Kaposi's Sarcoma Herpesvirus Processivity Factor-8 Functions as a Dimer in DNA Synthesis Journal of Biological Chemistry ·Xulin Chen, Kai Lin, Robert P. Ricciardi	2004	34
19	A rapid plate assay for the screening of inhibitors against herpesvirus DNA polymerases and processivity factors Journal of Virological Methods ·Kai Lin, Robert P. Ricciardi	2000	18
20	The 41-kDa Protein of Human Herpesvirus 6 Specifically Binds to Viral DNA Polymerase and Greatly Increases DNA Synthesis Virology ·Kai Lin, Robert P. Ricciardi	1998	22

About Kai Lin

Kai Lin is a scholar working on Hepatology, Virology, Infectious Diseases, Epidemiology and Oncology, having authored 50 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (15 papers), Signaling Pathways in Disease (11 papers), HIV/AIDS drug development and treatment (9 papers), Herpesvirus Infections and Treatments (5 papers), Viral-associated cancers and disorders (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Hepatology (1.0k citations), Virology (200 citations), Infectious Diseases (588 citations), Epidemiology (919 citations) and Molecular Biology (579 citations). Kai Lin has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Chao Lin, Ann D. Kwong, Robert B. Perni, Sue Ma, Philippe Gallay, Robert P. Ricciardi, Yu-Ping Luong, Cynthia A. Gates, Yunyi Wei and B. Govinda Rao. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Biological Chemistry, Journal of Hepatology, Bioorganic & Medicinal Chemistry Letters and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact